pastevents.paradigmglobalevents.com

Pharma End-to-End Supply Chain 2014

http://www.pastevents.paradigmglobalevents.com/pharma-end-to-end-supply-chain-2014

Pharma End-to-End Supply Chain 2014. Supply Chain Strategy and Management. Janice Kite, MBA, MCMI, MIBC, Traceability Director Healthcare, GS1 Global Office. Martin FitzGerald, deputy to the Director General, GIRP. Matthew Moran, Director, PharmaChemical Ireland. Richard Bergström, Director General, European Federation of Pharmaceutical, Industries and Associations (EFPIA). Christopher Gallwas, Head of Networking Planning (GPO) Boehringer Ingelheim. Christopher is responsible for all network planning rel...

Biosimilars Global Congress 2015 Europe

http://www.pastevents.paradigmglobalevents.com/biosimilars-global-congress-2015-europe

Biosimilars Global Congress 2015 Europe. Over the last decade, there has been a swift increase in the quantity of biological medicines that have received regulatory approval globally. To obtain approval for consumption, a biosimilar medicine which is medicine that is develop to be similar to an existing biological medicine, have to establish that they are as safe and effective as the original reference medicine and have the same quality. Follow on Biologics/Follow on Proteins/Biosimilars. Quality Affairs...

Health Economics Global Congress 2015 Europe

http://www.pastevents.paradigmglobalevents.com/health-economics-global-congress-2015-europe

Health Economics Global Congress 2015 Europe. The pharmaceutical industry is in a state of flux and with many drugs going off-patent in 2015 affecting drugmakers’ billions of sales. With this change, manufacturers have to look at ways to reduce costs and improve profit margins whilst promising safety and efficacy of their medicines. Who Will You Meet. Health Economics and Outcomes Research. Payers, HTA Officials and Physicians. Will Dunlop, Head of Market Access, MUNDIPHARMA INTERNATIONAL, UK. Prof Micha...

Orphan Drugs & Rare Diseases Congress 2016 Europe

http://www.pastevents.paradigmglobalevents.com/orphan-drugs-rare-diseases-global-congress-2016-europe

Orphan Drugs and Rare Diseases Congress 2016 Europe. In recent years, several new rare diseases are being included in clinical trials for the development of orphan drug candidate. Oncology, Genetic diseases, Autoimmune, pulmonary disease, Central nervous system and others are main focus of orphan drug developers. All of these diseases have large patient base but their rare forms doesn’t have suitable therapeutics which reflects the marketing potential of orphan drugs in these segments. Who Will You Meet.

Food & Beverage Global Congress 2015 Europe

http://www.pastevents.paradigmglobalevents.com/food-and-beverage-global-congress-2015-europe

Food and Beverage Global Congress 2015 Europe. Are proud to present The Food and Beverage Global Congress 2015 Europe. Who Will You Meet. Chief Executive, Executive Directors, Vice Presidents, Department Heads and Team Leaders and Managers working within:. Government, Authorities and Regulators. Consulting and Legal Advisory. Gain Latest Insights On:. Global and Regional Megatrends:. How Food Companies Innovate to Meet the Shift in Consumption Power? Challenges in the Globalisation of Food Production.